dc.contributor.author | SERTTAŞ, RIZA | |
dc.contributor.author | Turkekul, Kader | |
dc.contributor.author | DIBIRDIK, İLKER | |
dc.contributor.author | Bilir, Ayhan | |
dc.contributor.author | ERDOGAN, SUAT | |
dc.contributor.author | DOĞANLAR, OGUZHAN | |
dc.contributor.author | DOĞANLAR, ZEYNEP BANU | |
dc.date.accessioned | 2021-03-03T07:35:48Z | |
dc.date.available | 2021-03-03T07:35:48Z | |
dc.identifier.citation | ERDOGAN S., DOĞANLAR O., DOĞANLAR Z. B. , SERTTAŞ R., Turkekul K., DIBIRDIK İ., Bilir A., "The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-kappa B signaling", LIFE SCIENCES, cilt.162, ss.77-86, 2016 | |
dc.identifier.issn | 0024-3205 | |
dc.identifier.other | av_12cab9cd-1c8c-4005-aa87-a25668050e64 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/18085 | |
dc.identifier.uri | https://doi.org/10.1016/j.lfs.2016.08.019 | |
dc.description.abstract | Aims: Cancer stem cells (CSCs) are involved in drug resistance, metastasis and recurrence of cancers. The efficacy of apigenin on cell survival, apoptosis, migration and stemness properties were analyzed in CSCs. | |
dc.language.iso | eng | |
dc.subject | Temel Bilimler | |
dc.subject | TIP, ARAŞTIRMA VE DENEYSEL | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıbbi Ekoloji ve Hidroklimatoloji | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.title | The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-kappa B signaling | |
dc.type | Makale | |
dc.relation.journal | LIFE SCIENCES | |
dc.contributor.department | Trakya Üniversitesi , Tıp Fakültesi , Tıbbi Biyoloji | |
dc.identifier.volume | 162 | |
dc.identifier.startpage | 77 | |
dc.identifier.endpage | 86 | |
dc.contributor.firstauthorID | 235393 | |